0000950170-24-004645.txt : 20240116 0000950170-24-004645.hdr.sgml : 20240116 20240116162946 ACCESSION NUMBER: 0000950170-24-004645 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240112 FILED AS OF DATE: 20240116 DATE AS OF CHANGE: 20240116 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schreiber Taylor CENTRAL INDEX KEY: 0001601942 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39593 FILM NUMBER: 24535539 MAIL ADDRESS: STREET 1: 100 EUROPA DRIVE CITY: CHAPEL HILL STATE: NC ZIP: 27517 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Shattuck Labs, Inc. CENTRAL INDEX KEY: 0001680367 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 812575858 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 W. 5TH STREET CITY: AUSTIN STATE: TX ZIP: 78701 BUSINESS PHONE: 512-900-4690 MAIL ADDRESS: STREET 1: 500 W. 5TH STREET CITY: AUSTIN STATE: TX ZIP: 78701 4 1 ownership.xml 4 X0508 4 2024-01-12 0001680367 Shattuck Labs, Inc. STTK 0001601942 Schreiber Taylor C/O SHATTUCK LABS, INC. 500 W. 5TH STREET, SUITE 1200 AUSTIN TX 78701 true true false false Chief Executive Officer false Stock Option (Right to Buy) 9.41 2024-01-12 4 A false 330100 0.00 A 2034-01-12 Common Stock 330100 330100 D This option represents the right to purchase a total of 330,100 shares of the Issuer's common stock, one quarter of which will vest on January 12, 2025, with the remaining three quarters vesting in equal monthly installments through January 12, 2028, subject to the Reporting Person's continued service to the Issuer. /s/ Andrew R. Neill, Attorney-in-Fact for Taylor Schreiber 2024-01-16